Anti-thyroid medications lower thyroid hormone levels and lead to sustained reduction in autoimmune damage to the thyroid in people with Graves' disease.

We analyzed the available evidence on anti-thyroid medications and Graves’ disease, and what we’ve found so far is mixed. Some studies suggest these medications reduce thyroid hormone levels and may lead to a lasting decrease in autoimmune activity against the thyroid [1]. Other studies, however, do not show the same pattern, and the results vary across different groups of people and treatment durations. Anti-thyroid medications work by blocking the thyroid’s ability to make excess hormones, which is common in Graves’ disease — a condition where the immune system mistakenly attacks the thyroid, causing it to overproduce hormones. We saw 54 studies or assertions that reported a reduction in hormone levels and signs of reduced immune damage after using these drugs. But we also found 43 studies or assertions that did not observe this effect consistently, or found that hormone levels returned to high levels after stopping treatment. The evidence we’ve reviewed leans toward the idea that these medications can help lower hormone levels in the short term, and in some cases, may lead to a period of remission — meaning the disease becomes quieter without ongoing treatment. But remission doesn’t happen for everyone, and it’s hard to predict who it will work for. We also don’t have enough detail to say whether the reduction in autoimmune damage is lasting or just temporary. What we’ve found so far doesn’t confirm that these drugs cure Graves’ disease, nor does it rule out their usefulness. The results depend on the person, the dose, how long they’re taken, and how remission is measured. In everyday terms: These medications can help bring thyroid hormone levels down, and for some people, the condition stays under control even after stopping the drugs — but for others, it comes back. There’s no one-size-fits-all answer yet.